Endogeneous peptide profiling of cerebrospinal fluid by MALDI‐TOF mass spectrometry: Optimization of magnetic bead‐based peptide capture and analysis of preanalytical variables
- 2 November 2007
- journal article
- review article
- Published by Wiley in Proteomics – Clinical Applications
- Vol. 1 (11) , 1385-1392
- https://doi.org/10.1002/prca.200700330
Abstract
Cerebrospinal fluid (CSF) perfuses the brain and spinal cord. CSF contains peptides and proteins important for brain physiology and potentially also relevant to brain pathology. High-throughput endogeneous peptide profiling by MS is an emerging approach for disease diagnosis and biomarker discovery. A magnetic bead-based method for off-line serum peptide capture coupled to MALDI-TOF-MS has been introduced recently. In this study, we optimize the peptide capture method for profiling of CSF and investigate the effect of a number of preanalytical variables. The CSF profiles contain ∼100 reliably detected peptides at m/z 800–4000 with reproducible ion intensities (average 7% CV). The investigated preanalytical variables include: time at room temperature (RT) before storage, storage temperature, freeze-thawing cycles, and blood contamination. The CSF peptidome (<20 kDa) is relatively stable and can withstand a few hours at RT and several freeze-thaw cycles. Several peptides sensitive to storage at −20°C, including Cystatin C, were assigned based on mass or identified by MS/MS. Hemoglobin α and β chains were detected in blood contaminated samples, at levels invisible to the eye (0.01%). These peptides may be used for quality control in a MALDI-TOF-MS screening strategy to select high quality samples for in-depth proteomics analysis in disease studies.Keywords
This publication has 10 references indexed in Scilit:
- Automated serum peptide profiling using novel magnetic C18 beads off-line coupled to MALDI-TOF-MSProteomics – Clinical Applications, 2007
- A combined dataset of human cerebrospinal fluid proteins identified by multi‐dimensional chromatography and tandem mass spectrometryProteomics, 2007
- The blood peptidome: a higher dimension of information content for cancer biomarker discoveryNature Reviews Cancer, 2006
- Proteomic-Based Biomarker Discovery with Emphasis on Cerebrospinal Fluid and Multiple SclerosisCurrent Pharmaceutical Biotechnology, 2006
- Serum peptidome for cancer detection: spinning biologic trash into diagnostic goldJournal of Clinical Investigation, 2005
- The Peptidomics ConceptCombinatorial Chemistry & High Throughput Screening, 2005
- Truncated cystatin C in cerebrospiral fluid: Technical artefact or biological process?Proteomics, 2005
- The impact of blood contamination on the proteome of cerebrospinal fluidProteomics, 2005
- Biological markers in CSF and blood for axonal degeneration in multiple sclerosisThe Lancet Neurology, 2005
- Serum Peptide Profiling by Magnetic Particle-Assisted, Automated Sample Processing and MALDI-TOF Mass SpectrometryAnalytical Chemistry, 2004